Total Positions
83
Quarter
2025 Q4
Top Holding
RVMD (9.6%)
Top 10 Concentration
47.9%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
1-25 of 83
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
RVMD
REVOLUTION MEDI...
|
Healthcare | 9.63% | 7.33% |
#1
Prev: #1
|
5.9 | 250,000 | 14.3% |
P
S
|
2,000,000 | $159,300,000 | 2020 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PRAX
PRAXIS PRECISIO...
|
Healthcare | 6.68% | 0.59% |
#2
42
Prev: #44
|
5.0 | 250,000 | 200.0% |
P
S
|
375,000 | $110,527,500 | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IDYA
IDEAYA BIOSCIEN...
|
Healthcare | 6.53% | 5.49% |
#3
1
Prev: #2
|
4.7 | 875,000 | 38.9% |
P
S
|
3,125,000 | $108,031,250 | 2021 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
OLMA
OLEMA PHARMACEU...
|
Healthcare | 4.85% | 2.82% |
#4
8
Prev: #12
|
1.9 | no change | no change |
P
S
|
3,208,875 | $80,221,875 | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RVMD
CALL
REVOLUTION MEDI...
|
CALL Option | 4.81% | 4.19% |
#5
Prev: #5
|
1.9 | no change | no change |
P
S
|
1,000,000 | $79,650,000 | 2020 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CDTX
CIDARA THERAPEU...
|
Healthcare | 4.14% | 3.22% |
#6
1
Prev: #7
|
1.7 | -65,000 | -17.3% |
P
S
|
310,000 | $68,475,900 | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ABVX
ABIVAX SA
|
Healthcare | 3.26% | 3.16% |
#7
2
Prev: #9
|
1.3 | -15,000 | -3.6% |
P
S
|
400,000 | $53,942,000 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ERAS
ERASCA INC
|
Healthcare | 2.92% | 2.96% |
#8
2
Prev: #10
|
1.2 | -2,150,000 | -14.2% |
P
S
|
13,000,000 | $48,360,000 | 2024 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
OCUL
OCULAR THERAPEU...
|
Healthcare | 2.57% | 3.41% |
#9
3
Prev: #6
|
3.1 | 250,000 | 7.7% |
P
S
|
3,500,000 | $42,490,000 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
GPCR
STRUCTURE THERA...
|
Healthcare | 2.52% | 2.13% |
#10
9
Prev: #19
|
1.1 | -250,000 | -29.4% |
P
S
|
600,000 | $41,730,000 | 2023 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IRON
DISC MEDICINE I...
|
Healthcare | 2.45% | 2.67% |
#11
4
Prev: #15
|
3.0 | 60,000 | 13.3% |
P
S
|
510,000 | $40,499,100 | 2023 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MAZE
MAZE THERAPEUTI...
|
Healthcare | 2.38% | 2.85% |
#12
1
Prev: #11
|
1.0 | -277,300 | -22.6% |
P
S
|
950,000 | $39,358,500 | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TNGX
TANGO THERAPEUT...
|
Healthcare | 2.25% | 0.72% |
#13
24
Prev: #37
|
3.2 | 3,250,000 | 342.1% |
P
S
|
4,200,000 | $37,212,000 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RNA
AVIDITY BIOSCIE...
|
Healthcare | 2.18% | 2.34% |
#14
4
Prev: #18
|
0.9 | -100,000 | -16.7% |
P
S
|
500,000 | $36,065,000 | 2020 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BIIB
BIOGEN INC
|
Healthcare | 2.13% | 1.26% |
#15
15
Prev: #30
|
3.2 | 100,000 | 100.0% |
P
S
|
200,000 | $35,198,000 | 2023 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IMVT
IMMUNOVANT INC
|
Healthcare | 2.11% | 0.40% |
#16
32
Prev: #48
|
3.1 | 1,100,000 | 400.0% |
P
S
|
1,375,000 | $34,952,500 | 2020 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
JAZZ
JAZZ PHARMACEUT...
|
Healthcare | 2.05% | 2.36% |
#17
Prev: #17
|
0.8 | no change | no change |
P
S
|
200,000 | $34,000,000 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TERN
TERNS PHARMACEU...
|
Healthcare | 1.83% | — |
#18
Prev: #—
|
2.7 | 750,000 | no change |
NEW
|
750,000 | $30,300,000 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PCVX
VAXCYTE INC
|
Healthcare | 1.81% | 2.02% |
#19
3
Prev: #22
|
2.7 | 25,000 | 4.0% |
P
S
|
650,000 | $29,991,000 | 2020 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IMCR
IMMUNOCORE HLDG...
|
Healthcare | 1.78% | 2.77% |
#20
7
Prev: #13
|
0.7 | no change | no change |
P
S
|
850,000 | $29,503,500 | 2022 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
LBRX
LB PHARMACEUTIC...
|
Healthcare | 1.61% | 1.60% |
#21
6
Prev: #27
|
2.7 | 70,000 | 6.2% |
P
S
|
1,200,000 | $26,712,000 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
APLS
CALL
APELLIS PHARMAC...
|
CALL Option | 1.52% | 2.03% |
#22
1
Prev: #21
|
0.6 | no change | no change |
P
S
|
1,000,000 | $25,120,000 | 2019 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RCUS
CALL
ARCUS BIOSCIENC...
|
CALL Option | 1.51% | — |
#23
Prev: #—
|
2.6 | 1,050,000 | no change |
NEW
|
1,050,000 | $25,021,500 | 2023 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DYN
DYNE THERAPEUTI...
|
Healthcare | 1.48% | 2.72% |
#24
10
Prev: #14
|
0.7 | -1,150,000 | -47.9% |
P
S
|
1,250,000 | $24,450,000 | 2020 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DSGN
DESIGN THERAPEU...
|
Healthcare | 1.42% | 2.47% |
#25
9
Prev: #16
|
0.7 | -1,155,000 | -31.6% |
P
S
|
2,500,000 | $23,450,000 | 2021 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AKRO
AKERO THERAPEUT...
|
Healthcare | 0.00% | 5.11% |
Sold All 😨
(Was: #3) |
0.3 | -1,200,000 | -100.0% |
CLOSED
|
— | $— | 2022 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ARVN
ARVINAS INC
|
Healthcare | 0.00% | 4.26% |
Sold All 😨
(Was: #4) |
0.3 | -5,575,000 | -100.0% |
CLOSED
|
— | $— | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PTGX
PROTAGONIST THE...
|
Healthcare | 0.00% | 1.79% |
Sold All 😨
(Was: #25) |
0.3 | -300,000 | -100.0% |
CLOSED
|
— | $— | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
KROS
KEROS THERAPEUT...
|
Healthcare | 0.00% | 1.21% |
Sold All 😨
(Was: #32) |
0.3 | -850,000 | -100.0% |
CLOSED
|
— | $— | 2020 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
JANX
CALL
JANUX THERAPEUT...
|
CALL Option | 0.00% | 1.10% |
Sold All 😨
(Was: #35) |
0.3 | -500,000 | -100.0% |
CLOSED
|
— | $— | 2021 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
LRMR
CALL
LARIMAR THERAPE...
|
CALL Option | 0.00% | 0.72% |
Sold All 😨
(Was: #36) |
0.3 | -2,500,000 | -100.0% |
CLOSED
|
— | $— | 2020 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
COGT
COGENT BIOSCIEN...
|
Healthcare | 0.00% | 0.64% |
Sold All 😨
(Was: #39) |
0.3 | -500,000 | -100.0% |
CLOSED
|
— | $— | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IMRX
IMMUNEERING COR...
|
Healthcare | 0.00% | 0.60% |
Sold All 😨
(Was: #43) |
0.3 | -950,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SRRK
SCHOLAR ROCK HL...
|
Healthcare | 0.00% | 0.58% |
Sold All 😨
(Was: #45) |
0.3 | -175,000 | -100.0% |
CLOSED
|
— | $— | 2022 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
EPRX
EUPRAXIA PHARMA...
|
Healthcare | 0.00% | 0.48% |
Sold All 😨
(Was: #47) |
0.3 | -900,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ATXS
ASTRIA THERAPEU...
|
Healthcare | 0.00% | 0.33% |
Sold All 😨
(Was: #50) |
0.3 | -500,000 | -100.0% |
CLOSED
|
— | $— | 2022 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PEPG
PEPGEN INC
|
Healthcare | 0.00% | 0.31% |
Sold All 😨
(Was: #51) |
0.3 | -750,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ESPR
ESPERION THERAP...
|
Healthcare | 0.00% | 0.18% |
Sold All 😨
(Was: #54) |
0.3 | -750,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ALEC
CALL
ALECTOR INC
|
CALL Option | 0.00% | 0.13% |
Sold All 😨
(Was: #56) |
0.3 | -500,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-25 of 83 holdings